Ziprasidone Mesylate Injection, Powder, Lyophilized, For Solution
Product Images NDC 72266-160

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ziprasidone Mesylate (NDC 72266-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure.jpg (Structure)

FDA Label Image

Ziprasidone-carton.jpg (Ziprasidone Carton)

This text provides information about a medication called Ziprasidone Mesylate for Injection, which is intended for intramuscular use only. It contains details on the dosage, reconstitution instructions, and storage recommendations. The medication is presented in single-dose vials, with each mL containing ziprasidone mesylate equivalent to 20 mg of ziprasidone. The text also mentions the shelf life of the reconstituted solution, prescribing information, and the pharmaceutical company FOSUNPHARMA.*

FDA Label Image

Ziprasidone-label.jpg (Ziprasidone Label)

This is a description of a medication named "Ziprasidone" in single-dose vial form. The manufacturer is FOSUNPHARMA Bty. The medication is a Wissylate for Injection, indicated for intramuscular use. The NDC (National Drug Code) is 72266-160-01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.